460 related articles for article (PubMed ID: 19396032)
1. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor-alpha expression in pancreatic ductal adenocarcinoma: association with clinicopathological parameters, tumor proliferative capacity, and patients' survival.
Giaginis C; Katsamangou E; Tsourouflis G; Zizi-Serbetzoglou D; Kouraklis G; Theocharis S
Med Sci Monit; 2009 May; 15(5):BR148-56. PubMed ID: 19396032
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor gamma is highly expressed in pancreatic cancer and is associated with shorter overall survival times.
Kristiansen G; Jacob J; Buckendahl AC; Grützmann R; Alldinger I; Sipos B; Klöppel G; Bahra M; Langrehr JM; Neuhaus P; Dietel M; Pilarsky C
Clin Cancer Res; 2006 Nov; 12(21):6444-51. PubMed ID: 17085658
[TBL] [Abstract][Full Text] [Related]
3. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
Davidson B; Hadar R; Stavnes HT; Trope' CG; Reich R
Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507
[TBL] [Abstract][Full Text] [Related]
4. Pregnane X Receptor Expression in Human Pancreatic Adenocarcinoma: Associations With Clinicopathologic Parameters, Tumor Proliferative Capacity, Patients' Survival, and Retinoid X Receptor Expression.
Koutsounas I; Giaginis C; Alexandrou P; Zizi-Serbetzoglou A; Patsouris E; Kouraklis G; Theocharis S
Pancreas; 2015 Oct; 44(7):1134-40. PubMed ID: 26355550
[TBL] [Abstract][Full Text] [Related]
5. RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis.
Masui T; Doi R; Koshiba T; Fujimoto K; Tsuji S; Nakajima S; Koizumi M; Toyoda E; Tulachan S; Ito D; Kami K; Mori T; Wada M; Noda M; Imamura M
Clin Cancer Res; 2003 May; 9(5):1779-84. PubMed ID: 12738734
[TBL] [Abstract][Full Text] [Related]
6. Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma.
Liang JJ; Wang H; Rashid A; Tan TH; Hwang RF; Hamilton SR; Abbruzzese JL; Evans DB; Wang H
Clin Cancer Res; 2008 Nov; 14(21):7043-9. PubMed ID: 18981001
[TBL] [Abstract][Full Text] [Related]
7. Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome.
Pancione M; Forte N; Sabatino L; Tomaselli E; Parente D; Febbraro A; Colantuoni V
Hum Pathol; 2009 May; 40(5):714-25. PubMed ID: 19121846
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma.
Nitori N; Ino Y; Nakanishi Y; Yamada T; Honda K; Yanagihara K; Kosuge T; Kanai Y; Kitajima M; Hirohashi S
Clin Cancer Res; 2005 Apr; 11(7):2531-9. PubMed ID: 15814630
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of the immediate early response gene X-1 (IEX-1) expression in pancreatic cancer.
Sasada T; Azuma K; Hirai T; Hashida H; Kanai M; Yanagawa T; Takabayashi A
Ann Surg Oncol; 2008 Feb; 15(2):609-17. PubMed ID: 18026799
[TBL] [Abstract][Full Text] [Related]
10. High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients.
Vimalachandran D; Greenhalf W; Thompson C; Lüttges J; Prime W; Campbell F; Dodson A; Watson R; Crnogorac-Jurcevic T; Lemoine N; Neoptolemos J; Costello E
Cancer Res; 2005 Apr; 65(8):3218-25. PubMed ID: 15833853
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of vitamin D receptor and retinoid X receptor expression in renal cell carcinoma.
Obara W; Konda R; Akasaka S; Nakamura S; Sugawara A; Fujioka T
J Urol; 2007 Oct; 178(4 Pt 1):1497-503. PubMed ID: 17707062
[TBL] [Abstract][Full Text] [Related]
12. alpha-, beta- and chi-catenin expression in human pancreatic cancer.
Julkunen K; Mäkinen K; Kärjä V; Kosma VM; Eskelinen M
Anticancer Res; 2003; 23(6D):5043-7. PubMed ID: 14981965
[TBL] [Abstract][Full Text] [Related]
13. Expression of peroxisome proliferator-activated receptor gamma (PPAR-gamma) in canine nasal carcinomas.
Paciello O; Borzacchiello G; Varricchio E; Papparella S
J Vet Med A Physiol Pathol Clin Med; 2007 Oct; 54(8):406-10. PubMed ID: 17877580
[TBL] [Abstract][Full Text] [Related]
14. Cyclin E expression and outcome in pancreatic ductal adenocarcinoma.
Skalicky DA; Kench JG; Segara D; Coleman MJ; Sutherland RL; Henshall SM; Musgrove EA; Biankin AV
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1941-7. PubMed ID: 17035403
[TBL] [Abstract][Full Text] [Related]
15. Thrombospondin-1 expression as a prognostic predictor of pancreatic ductal carcinoma.
Tobita K; Kijima H; Dowaki S; Oida Y; Kashiwagi H; Ishii M; Sugio Y; Sekka T; Ohtani Y; Tanaka M; Inokuchi S; Makuuchi H
Int J Oncol; 2002 Dec; 21(6):1189-95. PubMed ID: 12429967
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptors and retinoid X receptor-alpha in term human gestational tissues: tissue specific and labour-associated changes.
Holdsworth-Carson SJ; Permezel M; Riley C; Rice GE; Lappas M
Placenta; 2009 Feb; 30(2):176-86. PubMed ID: 19070893
[TBL] [Abstract][Full Text] [Related]
17. Expression of pigment epithelium-derived factor decreases liver metastasis and correlates with favorable prognosis for patients with ductal pancreatic adenocarcinoma.
Uehara H; Miyamoto M; Kato K; Ebihara Y; Kaneko H; Hashimoto H; Murakami Y; Hase R; Takahashi R; Mega S; Shichinohe T; Kawarada Y; Itoh T; Okushiba S; Kondo S; Katoh H
Cancer Res; 2004 May; 64(10):3533-7. PubMed ID: 15150108
[TBL] [Abstract][Full Text] [Related]
18. Proteasome inhibitors induce peroxisome proliferator-activated receptor transactivation through RXR accumulation and a protein kinase C-dependent pathway.
Tsao WC; Wu HM; Chi KH; Chang YH; Lin WW
Exp Cell Res; 2005 Mar; 304(1):234-43. PubMed ID: 15707588
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor gamma expression in urothelial carcinomas of the bladder: association with differentiation, proliferation and clinical outcome.
Mylona E; Giannopoulou I; Diamantopoulou K; Bakarakos P; Nomikos A; Zervas A; Nakopoulou L
Eur J Surg Oncol; 2009 Feb; 35(2):197-201. PubMed ID: 18513919
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of immunohistochemical RhoA expression on survival in pancreatic ductal adenocarcinoma: a high-throughput analysis.
Dittert DD; Kielisch C; Alldinger I; Zietz C; Meyer W; Dobrowolski F; Saeger HD; Baretton GB
Hum Pathol; 2008 Jul; 39(7):1002-10. PubMed ID: 18495213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
